Mukka Proteins delays Vietnam acquisition to Dec 31, 2026

What Mukka Proteins announced

Mukka Proteins Limited filed an update with the National Stock Exchange on 30 June 2026 stating that the acquisition of its Vietnamese subsidiary, Mukka Proteins Vietnam Co., Ltd., will not be completed on the previously announced date of 30 June 2026. The company now expects the transaction to close on 31 December 2026.

"Delay in getting the regulatory approvals in Vietnam"

The filing references earlier intimations made on 26 July 2025, 4 August 2025 and 31 December 2025 under SEBI’s Regulation 30, and confirms that the delay is solely due to the time required to obtain the necessary approvals from Vietnamese authorities.

Acquisition details

• Acquiring entity: Mukka Proteins Limited (NSE: MUKKA)\
• Target entity: Mukka Proteins Vietnam Co., Ltd.\
• Consideration: Not to exceed Rs 10 lakh (Rupees Ten Lakhs Only). This amount corresponds to up to 70% of the issued and paid‑up share capital of the Vietnamese subsidiary.\
• Original expected completion: 30 June 2026.\
• Revised expected completion: 31 December 2026.\
• Reason for delay: Pending regulatory approvals in Vietnam.

The acquisition is being executed through a share‑transfer mechanism. No additional cash or securities are being issued beyond the stated Rs 10 lakh ceiling.

Key facts at a glance

Why this matters for investors

The delay does not alter the financial magnitude of the deal; the maximum outlay remains Rs 10 lakh, a material amount relative to Mukka Proteins’ balance sheet but unlikely to cause significant dilution. The primary risk highlighted is the regulatory timeline in Vietnam, which is outside the direct control of Indian shareholders. Until the Vietnamese authorities grant clearance, the share‑transfer cannot be consummated, meaning the subsidiary will continue to operate independently for the remainder of 2026. Investors should monitor any subsequent communications from the company regarding the status of those approvals.

Conclusion

Mukka Proteins Limited has formally extended the expected closing date of its acquisition of Mukka Proteins Vietnam to the end of 2026, citing regulatory hurdles in Vietnam as the cause. The transaction value remains capped at Rs 10 lakh, representing up to 70% of the target’s share capital. The company assures that it is taking all necessary steps to secure the pending approvals and complete the share transfer within the revised timeframe.